马德里社区的接触前预防计划：两年的经验。

IF 2.6 4区医学 Q3 INFECTIOUS DISEASES

Enfermedades infecciosas y microbiologia clinica Pub Date : 2025-03-01 DOI:10.1016/j.eimc.2024.03.014

Nuria Fernández Piñeiro , Oskar Ayerdi Aguirrebengoa , Eva Orviz García , Cristina González Pérez , Mar Vera García , Teresa Puerta López , Carmen Rodríguez Martín , Clara Lejarraga Cañas , Jorge Perez García , Begoña Baza Caraciolo , Monserrat González Polo , Florentina Alcudia Pérez , Marta Ruiz Fernández , Natividad Jerez Zamora , Diego Morales Irala , Beatriz López Centeno , Daniele Alioto , José Manuel Martínez Sesmero , Vicente Estrada Pérez , María Teresa Benítez Gimenez , Jorge del Romero Guerrero

{"title":"马德里社区的接触前预防计划：两年的经验。","authors":"Nuria Fernández Piñeiro , Oskar Ayerdi Aguirrebengoa , Eva Orviz García , Cristina González Pérez , Mar Vera García , Teresa Puerta López , Carmen Rodríguez Martín , Clara Lejarraga Cañas , Jorge Perez García , Begoña Baza Caraciolo , Monserrat González Polo , Florentina Alcudia Pérez , Marta Ruiz Fernández , Natividad Jerez Zamora , Diego Morales Irala , Beatriz López Centeno , Daniele Alioto , José Manuel Martínez Sesmero , Vicente Estrada Pérez , María Teresa Benítez Gimenez , Jorge del Romero Guerrero","doi":"10.1016/j.eimc.2024.03.014","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Pre-exposure prophylaxis (PrEP) against the human immunodeficiency virus (HIV) is an effective and safe preventive measure. However, it has not reached all target users who could benefit from it.</div><div>The study aimed to understand the sociodemographic, clinical and behavioral baseline characteristics of PrEP users. As a secondary objective, the use of concomitant medication and drug consumption were described.</div></div><div><h3>Methodology</h3><div>Observational, retrospective and descriptive study of the sociodemographic, clinical and behavioral characteristics of the users who were included in the PrEP program of the Community of Madrid during the first two years of experience.</div></div><div><h3>Results</h3><div>Two thousand two hundred fifty-six PrEP users were included, 99.0% men, with a mean age of 36.9 years (SD: 8.68). 33.1% presented a sexually transmitted infection (STI) on the first visit, highlighting chlamydiasis and rectal gonococci. 70.4% reported using drugs associated with sex, and 42.4% participated in chemsex sessions in the last 3 months. A high percentage of users with concomitant medication was observed (37.6%), highlighting drugs related to mental health and alopecia.</div></div><div><h3>Conclusions</h3><div>A multidisciplinary approach is required to cover all the needs of PrEP users, including mental health evaluation measures and addiction treatment with the clinical approach.</div></div>","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"43 3","pages":"Pages 133-138"},"PeriodicalIF":2.6000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Programa de profilaxis pre-exposición de la Comunidad de Madrid: 2 años de experiencia\",\"authors\":\"Nuria Fernández Piñeiro , Oskar Ayerdi Aguirrebengoa , Eva Orviz García , Cristina González Pérez , Mar Vera García , Teresa Puerta López , Carmen Rodríguez Martín , Clara Lejarraga Cañas , Jorge Perez García , Begoña Baza Caraciolo , Monserrat González Polo , Florentina Alcudia Pérez , Marta Ruiz Fernández , Natividad Jerez Zamora , Diego Morales Irala , Beatriz López Centeno , Daniele Alioto , José Manuel Martínez Sesmero , Vicente Estrada Pérez , María Teresa Benítez Gimenez , Jorge del Romero Guerrero\",\"doi\":\"10.1016/j.eimc.2024.03.014\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><div>Pre-exposure prophylaxis (PrEP) against the human immunodeficiency virus (HIV) is an effective and safe preventive measure. However, it has not reached all target users who could benefit from it.</div><div>The study aimed to understand the sociodemographic, clinical and behavioral baseline characteristics of PrEP users. As a secondary objective, the use of concomitant medication and drug consumption were described.</div></div><div><h3>Methodology</h3><div>Observational, retrospective and descriptive study of the sociodemographic, clinical and behavioral characteristics of the users who were included in the PrEP program of the Community of Madrid during the first two years of experience.</div></div><div><h3>Results</h3><div>Two thousand two hundred fifty-six PrEP users were included, 99.0% men, with a mean age of 36.9 years (SD: 8.68). 33.1% presented a sexually transmitted infection (STI) on the first visit, highlighting chlamydiasis and rectal gonococci. 70.4% reported using drugs associated with sex, and 42.4% participated in chemsex sessions in the last 3 months. A high percentage of users with concomitant medication was observed (37.6%), highlighting drugs related to mental health and alopecia.</div></div><div><h3>Conclusions</h3><div>A multidisciplinary approach is required to cover all the needs of PrEP users, including mental health evaluation measures and addiction treatment with the clinical approach.</div></div>\",\"PeriodicalId\":11608,\"journal\":{\"name\":\"Enfermedades infecciosas y microbiologia clinica\",\"volume\":\"43 3\",\"pages\":\"Pages 133-138\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Enfermedades infecciosas y microbiologia clinica\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0213005X24002301\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Enfermedades infecciosas y microbiologia clinica","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0213005X24002301","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}

引用次数: 0

摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Programa de profilaxis pre-exposición de la Comunidad de Madrid: 2 años de experiencia

Introduction

Pre-exposure prophylaxis (PrEP) against the human immunodeficiency virus (HIV) is an effective and safe preventive measure. However, it has not reached all target users who could benefit from it.

The study aimed to understand the sociodemographic, clinical and behavioral baseline characteristics of PrEP users. As a secondary objective, the use of concomitant medication and drug consumption were described.

Methodology

Observational, retrospective and descriptive study of the sociodemographic, clinical and behavioral characteristics of the users who were included in the PrEP program of the Community of Madrid during the first two years of experience.

Results

Two thousand two hundred fifty-six PrEP users were included, 99.0% men, with a mean age of 36.9 years (SD: 8.68). 33.1% presented a sexually transmitted infection (STI) on the first visit, highlighting chlamydiasis and rectal gonococci. 70.4% reported using drugs associated with sex, and 42.4% participated in chemsex sessions in the last 3 months. A high percentage of users with concomitant medication was observed (37.6%), highlighting drugs related to mental health and alopecia.

Conclusions

A multidisciplinary approach is required to cover all the needs of PrEP users, including mental health evaluation measures and addiction treatment with the clinical approach.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Enfermedades infecciosas y microbiologia clinica 医学-传染病学

CiteScore

2.10

自引率

8.00%

发文量

194

审稿时长

29 days

期刊介绍： Hoy está universalmente reconocida la renovada y creciente importancia de la patología infecciosa: aparición de nuevos agentes patógenos, de cepas resistentes, de procesos con expresión clínica hasta ahora desconocida, de cuadros de una gran complejidad. Paralelamente, la Microbiología y la Infectología Clínicas han experimentado un gran desarrollo como respuesta al reto planteado por la actual patología infecciosa. Enfermedades Infecciosas y Microbiología Clínica es la Publicación Oficial de la Sociedad Española SEIMC. Cumple con la garantía científica de esta Sociedad, la doble función de difundir trabajos de investigación, tanto clínicos como microbiológicos, referidos a la patología infecciosa, y contribuye a la formación continuada de los interesados en aquella patología mediante artículos orientados a ese fin y elaborados por autores de la mayor calificación invitados por la revista.